Stephen V Liu

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Stephen V Liu
Sep 10, 2024, 11:17 | Insight
Jennifer Marks: Our MET-working paper in collaboration with Caris Life Sciences
Jennifer Marks shared a post on X: “Our MET-working paper in collaboration with Caris Life…
Sep 10, 2024, 11:08 | Societies
Special WCLC24 Lung Cancer Considered episode
IASLC (International Association for the Study of Lung Cancer) shared a post on X: “…
Sep 10, 2024, 05:38 | Blog
WCLC24 Social Media Ambassadors
Narjust Florez shared a post on X: "Our social media ambassadors for WCLC24. Make sure…
Sep 9, 2024, 13:41 | Societies
Highlights from WCLC24 by Stephen V Liu
The WCLC24 is taking place at the San Diego Convention Center from September 7 to…
Sep 9, 2024, 09:35 | Blog
Maria Antonia Vélez: Excellent talk by Stephen V. Liu on how to give a Master Class on Scientific presentations
Maria Antonia Vélez shared a post on X: ''Excellent talk by Stephen V. Liu on…
Sep 9, 2024, 07:17 | Societies
Julie Brahmer received Paul A. Bunn Scientific Award
WCLC is a major international event focused on the latest advancements in lung cancer research,…
Sep 8, 2024, 13:51 | Societies
20 Posts Not To Miss from Day 1 of WCLC24
The International Association for the Study of Lung Cancer (IASLC) is a global, multidisciplinary organization…
Sep 8, 2024, 12:17 | Blog
Stephen V Liu: "Do You Know Your Targets" Quiz show on September 9th at WCLC24
Stephen V Liu shared a post on X: "Join us at WCLC24 on Monday, September…
Sep 5, 2024, 15:21 | Blog
Stephen V Liu: Mark your calendar for Chemotherapy Foundation Symposium 2024
Stephen V Liu shared a post on X: "With so many updates across cancer types, mark…
Sep 4, 2024, 15:28 | Blog
Hidehito Horinouchi: Early Career Investigator Workshop at WCLC24
Hidehito Horinouchi shared a post on X: ''WCLC24. Early Career Investigator Workshop. Faculties: Narjust Florez, Fabio…
Sep 1, 2024, 18:05 | Insight
Stephen Liu: The role of adjuvant chemotherapy when adjuvant ALK TKI is planned
Stephen Liu shared a post on X: "Dr. Joshua Reuss takes center stage at DC…
Aug 23, 2024, 17:15 | Blog
Brian Shields: AI evaluates recent FDA decision
Brian Shields, Creator of KOL Pulse AI, shared on LinkedIn: "AI evaluates recent FDA decision:…
Aug 23, 2024, 14:21 | Drugs
Stephen V Liu: How do we select the optimal regimen for EGFR NSCLC?
Stephen V Liu shared on X: "With FLAURA (osimertinib alone), FLAURA2 (osimertinib with chemotherapy), and…
Aug 20, 2024, 09:02 | Blog
Stephen V Liu: Join an inspiring WCLC 24 program and celebrate the IASLC 50y
Stephen V Liu shared a post on X: "Join us in 3 weeks for an inspiring…
Aug 19, 2024, 08:29 | Insight
4 leading Chinese lung cancer experts to discuss current research/clinical issues, in Mandarin - IASLC
Stephen V. Liu shared a post by IASLC on X, adding: “Thanks to Drs. Chunxia…
Aug 17, 2024, 15:47 | Blog
Stephen V Liu: Nagla Abdel Karim joins DC Lung24 to discuss targeted therapy in NSCLC
Stephen V Liu shared on X: "Dr. Nagla Abdel Karim joins DC Lung24 to guide discussions…
Aug 16, 2024, 14:13 | Insight
OS rates for IMpower133 and IMbrella A extension study in SCLC
Biagio Ricciuti shared a paper by Martin Reck et al. on X, adding: “Five-year survival…
Aug 14, 2024, 07:04 | Insight
ES-SCLC 5-year survival outcomes inIMpower133 and IMbrella study
Katsuaki Maehara, Director of Medical Education Colleagues, shared a post on X, about recent paper…
Aug 13, 2024, 09:57 | Blog
Zosia Piotrowska about what's next for EGFR at DCLung24
Stephen V Liu posted on X: "Dr. Zosia Piotrowska from MGH Thoracic Oncology will discuss…
Aug 12, 2024, 16:45 | Blog
Chul Kim on the advances in treating lung cancer with exon 20 or mutation at DCLung24
Stephen V Liu shared on X: "Dr. Chul Kim will discuss advances in treating lung…
Aug 9, 2024, 06:23 | Blog
Stephen V Liu: The current and future utility of liquid biopsy and ctDNA at DC Lung24
Stephen V Liu posted on X: "Dr. Natasha Leighl will speak at DC Lung24 on…
Aug 8, 2024, 07:50 | Insight
Narjust Florez: Amazing discussion with the leaders that made ALK + NSCLC a treatable disease
Narjust Florez shared a post by IASLC on X, adding: “Amazing discussion with the leaders…
Aug 8, 2024, 02:34 | Blog
Dr. Isabel Preeshagul will discuss perioperative targeted therapy for lung cancer at DCLung24
Stephen V Liu shared on X: “Dr. Isabel Preeshagul will discuss perioperative targeted therapy for…
Aug 7, 2024, 18:01 | Blog
Jarushka Naidoo: Survivorship in Lung Cancer, a great theme to usher in a new era in thoracic oncology
Jarushka Naidoo shared a post by LUNGevity Foundation on X, adding: "Survivorship in Lung Cancer,…
Aug 5, 2024, 14:45 | Blog
Stephen V Liu: Join me at the 19th annual New York Lung Cancers Symposium
Stephen V Liu shared on X: "Join me at the 19th annual New York Lung…
Aug 4, 2024, 06:50 | Insight
Sandip Patel joins DCLung24 with important perspective on artificial intelligence in healthcare
Stephen V Liu shared on X: "Dr. Sandip Patel joins DCLung24 with important perspective on…
Jul 30, 2024, 02:53 | Blog
Giannis Mountzios: Huge pleasure to discuss advances in Precision oncology in NSCLC with Elsa Anagnostou and Ferdinandos Skoulidis
Giannis Mountzios, Medical Oncologist at the Department of Medical Oncology in the Air Force General…
Jul 26, 2024, 06:20 | Blog
Hossein Borghaei discusses how CTLA4 remains relevant for NSCLC at DC Lung24
Stephen V Liu shared on X: "Dr. Hossein Borghaei from Fox Chase Cancer Center discusses how…
Jul 26, 2024, 00:27 | Blog
Stephen V Liu: Rapid communication on management of stage III NSCLC by ASCO
Stephen V Liu shared on X: "Latest ASCO rapid communication on management of stage III NSCLC.…
Jul 25, 2024, 21:48 | Insight
Stephen V Liu: What is the role for SRS to brain metastases up front for EGFR or ALK NSCLC?
Stephen V Liu shared a paper by Luke R.G. Pike et al. on X, adding: “What…
Jul 25, 2024, 14:28 | Blog
Stephen V Liu: Alexander Drilon joins DCLung24 to discuss RET fusions in NSCLC
Stephen V Liu shared on X: "Dr. Alexander Drilon joins DCLung24 to discuss RET fusions as…
Jul 24, 2024, 00:57 | Insight
Report on TROP2 expression across tumors
Stephen V Liu shared a paper by Dan Morgenstern-Kaplan et al, on X: "Report on…
Jul 23, 2024, 11:45 | Blog
Stephen V Liu: The International Lung Cancer Survivorship Conference is on September 20-21,2024
Stephen V Liu shared on X: "Join me at ILCSC24 on Sept 20 - 21 with…
Jul 21, 2024, 15:37 | Insight
Neoadjuvant osimertinib for resectable EGFR NSCLC
Stephen V Liu shared on X a recent paper by Collin M. Blakely et al.…
Jul 21, 2024, 09:29 | Blog
Stephen V Liu: Terri Conneran about the patient perspective on the value of research at DC Lung 24
Stephen V Liu shared on X:  . "Excited to welcome Terri Conneran of KRAS Kickers to…
Jul 20, 2024, 17:09 | Opinion
Stephen V Liu: Tina Cascone on Neoadjuvant and Perioperative Immunotherapy For Early Stage NSCLE At DCLung24
Stephen V Liu shared a post on X: "Dr. Tina Cascone from MD Anderson News…
Jul 20, 2024, 01:22 | Blog
Brigatinib in ROS1 NSCLC
Stephen V Liu shared a post on X: ''Brigatinib in ROS1 NSCLC (Phase II Barossa…
Jul 18, 2024, 11:08 | Blog
Stephen V Liu: Retrospective study looks at immunotherapy in patients with NSCLC and autoimmune condition
Stephen V Liu shared on X: "Retrospective NEJ047 study looks at immunotherapy in patients with NSCLC…
Jul 13, 2024, 14:20 | Blog
Samuel Kareff: Pan-tumoral analysis of TROP2 among solid tumors
Samuel Kareff, Hematology/Oncology Chief Fellow at the University of Miami Sylvester Comprehensive Cancer Center, shared…
Jul 10, 2024, 11:53 | Blog
Stephen V. Liu: Pittsburgh Annual Oncology Symposium Experts and Evidence 2024
Stephen V. Liu shared on X: “Join me for an update on Targeted Therapy in…
Jul 8, 2024, 18:02 | Blog
Stephen V. Liu: Brief update at utilization of lung cancer screening in the US
Stephen V. Liu shared on X: “Brief update at utilization of lung cancer screening in…
Jul 7, 2024, 17:51 | Blog
Stephen V. Liu: How do we encourage colleagues and patients to wait for biomarker results?
Stephen V. Liu shared on X: “Faced with an urgency to start therapy for newly…
Jul 7, 2024, 07:04 | Blog
Stephen V. Liu: Can we use ctDNA to personalize use of consolidation immunotherapy after chemoradiation?
Stephen V. Liu shared on X: “Can we use ctDNA to personalize use of consolidation…
Jul 6, 2024, 12:06 | Blog
Real world data on QTc prolongation with osimertinib
Stephen V Liu shared on X: "Real world data on QTc prolongation with osimertinib. 970 pts…
Jul 5, 2024, 10:25 | Blog
Stephen V Liu: Important dates for thoracic oncologists
Stephen V Liu shared on X: "For all thoracic oncologists out there, keep these dates…
Jul 5, 2024, 06:54 | Blog
Estela Rodriguez: Underreported toxicity of myopathy from EGFR TKIs
Estela Rodriguez shared a post by Stephen V Liu, on X: "Important to study under reported toxicity…
Jul 4, 2024, 11:48 | Insight
The Importance of Waiting for Biomarker Results in NSCLC
IASLC (International Association for the Study of Lung Cancer) shared a post on X: "Biomarkers…
Jul 3, 2024, 01:51 | Blog
Oncology Brothers: Stephen V Liu covering NSCLC where treatment is with curative intent
Oncology Brothers shared on X: "Stephen V Liu from Georgetown Lombardi covering NSCLC where treatment is…
Jul 2, 2024, 15:14 | Insight
Managing dose reduction without compromising outcomes of HR+ breast cancer
Stephen V Liu shared a post on X: “At the Upstate NY Cancer Symposium, Stephanie Graff…
Jul 1, 2024, 03:08 | Blog
Stephen V Liu: Phase III Adjuvant BR.31 study does not meet primary endpoint
Stephen V Liu shared on X: “Phase III ADJUVANT BR.31 study does not meet primary…
Jun 23, 2024, 10:44 | Blog
IV vs Subcutaneous amivantamab in EGFR NSCLC
Eric K. Singhi shared a post by Stephen V Liu, on X: "Absolutely agree with this! Compared with…
Jun 22, 2024, 09:57 | Blog
Upstate Cancer Symposium: June 29th and 30th - Oncology Brothers
Oncology Brothers shared a post on X:          . "Upstate NY Cancer…
Jun 21, 2024, 04:59 | Insight
Jarushka Naidoo: WCLC24 is fast approaching
Jarushka Naidoo shared a post by IASLC on X, adding: “WCLC24 is fast approaching! Look…
Jun 19, 2024, 03:53 | Societies
This year's ILCS24 will include a remarkable and global faculty
International Lung Cancer Summit (ILCS) shared on X: "This year's ILCS24 will include a remarkable…
Jun 19, 2024, 02:03 | Blog
Stephen V Liu: Apply for the IASLC 10th Edition Staging and Prognostic Factors Group
Stephen V Liu shared a post on X: "Apply for the IASLC 10th Edition Staging and…
Jun 19, 2024, 01:35 | Blog
Stephen V Liu: Bittersweet day at Georgetown Lombardi Comprehensive Cancer Center as Jennifer Marks has her last thoracic clinic with me
Stephen V Liu shared a post on X: “Bittersweet day at Georgetown Lombardi Comprehensive Cancer…
Jun 15, 2024, 05:08 | Blog
Kelsey Pan: Happy to share our analysis of NSCLC patients with germline EGFR mutations
Kelsey Pan, Heme/Onc Chief Fellow at MD Anderson Cancer Center, shared a post by Stephen V Liu, on…
Jun 14, 2024, 15:12 | Blog
Stephen V Liu: Second episode of the IASLC podcast
Stephen V Liu shared on X: " So much lung cancer data from ASCO24 we…
Jun 14, 2024, 03:35 | Blog
Stephen V Liu: ASCO24 highlights with Drs. Lecia Sequist and David R. Spigel
Stephen V Liu shared the following on X: “In the latest episode of the IASLC…
Jun 13, 2024, 07:33 | Blog
Narjust Florez: Stay tuned for a discussion on lung cancer data presented at ASCO24
Narjust Florez shared a post on X: "Stay tuned for an incredible discussion about the lung…
Jun 9, 2024, 01:38 | Insight
Stephen V Liu reflects on OS from PACIFIC-R
Stephen V Liu shared the following insight on X: "OS from PACIFIC-R: real-world outcomes with…
Jun 1, 2024, 14:46 | Societies
15 Posts From ASCO24 Day 1 You Should Not Miss!
The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting is being held from May…
May 26, 2024, 08:37 | Blog
Giannis Mountzios: New Edition of the ESMO Essentials in Thoracic Oncology has officially kicked-off
Giannis Mountzios, Medical Oncologist at the Department of Medical Oncology in the Air Force General Hospital…
May 21, 2024, 05:50 | Insight
Stephen V Liu: Lots of great work at the WCLC24 planning meeting
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Georgetown University at Lombardi…
May 8, 2024, 00:58 | Blog
Stephen V Liu: Dr. Passiglia Fra at Rome Lung 24 illustrates the limited role of immunotherapy in driver positive NSCLC
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Georgetown University at Lombardi…
May 8, 2024, 00:50 | Blog
Stephen V Liu: Dr. Giulia Pasello at Rome Lung 24 discusses duration of immunotherapy for NSCLC
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Georgetown University at Lombardi…
May 2, 2024, 14:14 | Blog
Stephen V Liu discusses KRAS mutant NSCLC with Veluswamy and Mariana Brandao - IASLC
International Association for the Study of Lung Cancer (IASLC) shared on X: “KRAS mutations are…
Apr 26, 2024, 19:43 | Opinion
Stephen V Liu: Early registration is open for WCLC24!
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Lombardi Comprehensive Cancer Center,…
Apr 26, 2024, 17:36 | Blog
Heidi Nafman-Onda: Starstruck at Texaslung24
Heidi Nafman-Onda, Fitness Trainer, Health Educator, Lung Cancer survivor/advocate, Co-Founder of The White Ribbon Project,…
Apr 26, 2024, 15:14 | Blog
Stephen V Liu: Narjust Florez at TexasLung24 explains why and how social media can help the practicing oncologist
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Georgetown University, shared a post on…
Apr 13, 2024, 12:35 | Opinion
Stephen V Liu: Some guidance on the management of adverse events with sotorasib in KRAS G12C NSCLC Lung Cancer Journal
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Georgetown University, shared a post…
Apr 13, 2024, 07:50 | Blog
Stephen Liu: Help identify areas of ongoing need and provide greater understanding of how we can impact DEI
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Lombardi Comprehensive Cancer Center,…
Mar 31, 2024, 23:12 | Insight
Stephen V Liu: Results from phase III CONTACT-01 trial Journal of Clinical Oncology
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Lombardi Comprehensive Cancer Center,…
Mar 30, 2024, 14:25 | Blog
Stephen V Liu Leads Top Influencers at ELCC 2024 by LARVOL
LARVOL/X recently shared a list of top influencers and their impact from ELCC 2024, where…
Mar 27, 2024, 14:11 | Blog
Stephen V Liu: ELCC24 Great discussion of Antibody drug conjugates toxicity from Dr. Jarushka Naidoo, noting that each component of the antibody drug conjugate will impact toxicity
Mar 25, 2024, 15:15 | Societies
25 Posts Not To Miss From ELCC 2024
The European Lung Cancer Congress (ELCC 2024) took place in Prague, Czech Republic, from 20th…
Mar 21, 2024, 15:19 | Blog
Jarushka Naidoo: Getting ready to plan ASCO24
Jarushka Naidoo shared a post on X/Twitter: “Getting ready to plan ASCO24! And with a…
Mar 11, 2024, 18:00 | Societies
Florez Lab: A fantastic discussion on Nivolumab and Non-Small Cell Lung Cancer
Florez Lab posted on X/Twitter: "What podcast should you listen to today? In this episode…
Mar 5, 2024, 00:54 | Blog
Stephen V. Liu: Report Clinical Lung Cancer shows improving lung cancer survival in the Veterans Administration
Stephen V. Liu, Director of Thoracic Oncology and Developmental Therapeutics at Lombardi Comprehensive Cancer Center,…
Feb 25, 2024, 15:08 | Blog
Christine Garcia: Enjoyed this episode on the past 3 years of the IASLC LCC podcast
Christine Garcia, Director of the Hematology and Oncology Fellowship Program at Weill Cornell Medicine, shared…
Feb 5, 2024, 11:27 | Insight
Stephen V Liu: The optimal strategy for unresectable stage III NSCLC after chemoradiation in EGFR mutant NSCLC
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Lombardi Comprehensive Cancer Center,…
Jan 30, 2024, 10:56 | Blog
Stephen V Liu: Congratulations to Drs. Glenn J. Hanna, Annie Silk and team - huge achievement!
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Lombardi Comprehensive Cancer Center,…
Jan 16, 2024, 05:48 | Drugs
Stephen V Liu: Many updates in the 1.2024 National Comprehensive Cancer Network (NCCN) NSCLC guidelines
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Lombardi Comprehensive Cancer Center,…
Jan 10, 2024, 12:36 | Blog,Drugs
Stephen V Liu: Need more data on PKs with crushing TKI pills
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Lombardi Comprehensive Cancer Center,…
Jan 8, 2024, 14:29 | Blog
Stephen V Liu: I discuss managing relapsed Small-Cell Lung Cancer with Fiona Blackhall and Misty Dawn Shields
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at the Lombardi Comprehensive Cancer…
Dec 13, 2023, 17:12 | Blog
Chul Kim: It truly takes a village to conduct and care for patients in clinical trials
Chul Kim, Thoracic Medical Oncologist at Georgetown University, shared on X/Twitter: "It truly takes a…
Nov 28, 2023, 18:00 | Drugs
Stephen V Liu: Report on real world efficacy and safety of amivantamab including off label use
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at the Lombardi Comprehensive Cancer…
Nov 14, 2023, 18:53 | Blog
Narjust Florez: Stephen V Liu discusses a REALISTIC approach to working with our patients and their families while waiting for biomarker testing
Narjust Florez, shared a post on X/Twitter: "Dr. Stephen V Liu discusses a REALISTIC approach…
Oct 24, 2023, 13:45 | Blog
Stephen V Liu: ESMO23 - Dr. Solange Peters presents the PERLA randomized phase II study
Quoting Stephen V Liu, Associate Professor of Medicine and the Director of Thoracic Oncology at Georgetown University,…
Oct 17, 2023, 16:44 | Insight
Stephen V Liu reflected on the OCEAN study published in the Journal of Thoracic Oncology
Quoting Stephen V Liu, Associate Professor of Medicine and the Director of Thoracic Oncology at Georgetown…
Oct 10, 2023, 15:47 | Opinion
Jill Feldman: The true art of oncology is understanding that the right approach/treatment MUST align with the soul, preferences and dreams of the patient (and fam) in front of you.
Sep 11, 2023, 18:17 | Blog
Stephen V Liu: Dr. Eric Lim's presentation of MARS2 was the best presentation I think I have ever seen.
Quoting Stephen V Liu, Associate Professor of Medicine and the Director of Thoracic Oncology at Georgetown…
Sep 11, 2023, 17:32 | Blog
Neal Augenstein: As a journalist and lung cancer patient, here’s an example of the power of podcast.
Quoting Neal Augenstein on X/Twitter: ''As a journalist and lung cancer patient, here’s an example of…
Sep 10, 2023, 22:55 | Blog
Stephen V Liu: Big congratulations to Dr. Suresh Ramalingam - winner of the IASLC Paul Bunn Scientific Award at World Conference on Lung Cancer 2023.
Quoting Stephen V Liu, Director of Thoracic Oncology & Developmental Therapeutics at Georgetown Lombardi, on…
Sep 7, 2023, 19:58 | Insight
Vivek Subbiah: Super delighted to Join Dr. Stephen V Liu to share my thoughts...
Quoting Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, on…
Aug 29, 2023, 18:57 | Blog
Stephen V Liu: Join me in Singapore (or virtually) for WCLC23 on Saturday, September 9th.
Quoting Stephen V Liu, the Director of Thoracic Oncology & Developmental Therapeutics Lombardi Comprehensive Cancer…
Aug 13, 2023, 08:56 | Insight
Stephen V Liu: More data showing the importance of *waiting* for NGS results before starting non–small-cell lung cancer therapy whenever possible!
As per Stephen V. Liu, the Director of Thoracic Oncology and Head of Developmental Therapeutics at…
Aug 12, 2023, 15:49 | Insight
Stephen V Liu: Editorial New England Journal of Medicine from Dr. Christine Lovly, gives nice perspective on the phase III KEYNOTE 671 study in resectable non-small-cell lung cancer
Jul 5, 2023, 05:23 | Drugs
Cancer drug shortages continue - Stephen V Liu
Cancer drug shortages continue. Carboplatin, cisplatin, capecitabine, methotrexate, azacitadine - the list continues to grow…
12
All: 199 Posts: 101 - 200
Special Coverage